2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Multivisceral Transplantation Without an Ostomy – Experience With 15 Patients

T. Beduschi, J. Garcia, S. Nishida, A. Tekin, J. Fan, G. Selvaggi, P. Ruiz, R. Vianna.
Murine Veno-Arterial Extracorporeal Membrane Oxygenation (mVA-ECMO): A Novel Tool to Study the Molecular Biology of Mechanical Circulatory Support

A. Schenk,¹ J. Fallon,¹ M. Farrell,¹ R. Halter,² J. Yun.³
Muscle Mass Measurement Is Objective and More Predictive of Expected Mortality Than Functional Status in High MELD Liver Transplant Recipients

J. Nolte,¹ S. Gordon Burroughs,¹ D. Victor,¹ C. Mobley,¹ N. Yu,² T. Hirase,¹ A. Saharia,¹ A. Rajaraman,¹ L. Moore,¹ A. Gaber,¹ R. Ghobrial.¹
Mycophenolate Dose Reductions Contribute to Suboptimal Graft Outcomes in Kidney Transplant Recipients

K. Boyle, J. Fleming, D. Taber, K. Covert, J. Casale, C. Staino, N. Pilch, C. Mardis, H. Meadows, T. Srinivas, J. McGillicuddy, K. Chavin, C. Bratton, P. Baliga.
Mycophenolic Acid Area-Under-Curve (MPA AUC) Levels Sufficient to Prevent Donor-Specific Antibody (DSA) Formation Are Not Associated With Higher Rates of CMV/EBV/BK Viral Infections

S. Narins, D. Ladie, R. Saylor, E. Richards, H. Yang, M. Waybill.
Myeloid Cell-Specific Heme Oxygenase-1 Is Crucial for Hepatoprotection in Liver Ischemia-Reperfusion Injury

K. Nakamura,¹ M. Zhang,² B. Ke,¹ R. Busuttil,¹ J. Araujo,² J. Kupiec-Weglinski.¹
Myeloid Cells as a Key Mediator for Impairment of Transplant Tolerance by CMV Infection

L. Zhang,¹ X. Zhang,² H. Kang,¹ X.-F. Liu,² S. Yan,² J.-J. Wang,² M. Abecassis,² Z. Zhang,² M. Hummel,² X. Luo.^1,2
MYH9 Polymorphic Variants and Chronic Lesions in Transplanted Kidney Biopsy

J. Pazik,¹ M. Oldak,² Z. Lewandowski,³ D. Ozieblo,⁴ K. Michalska,⁵ A. Perkowska Ptasińska,¹ A. Sadowska,¹ M. Nowaczyk,⁵ J. Malejczyk,⁴ M. Durlik.¹
National Outcomes of Donation After Cardiac Death (DCD) Liver Transplantation Are Equivalent to Donation After Brain Death (DBD) Liver Transplantation Using Older (DBD) Donor Livers

R. Redfield, M. Rizzari, J. Scalea, L. Fernandez, A. D'Alessandro, J. Mezrich, D. Foley.
National Outcomes of Kidney Tranplantation from Diabetic Donors: A Mate-Kidney Analysis

J. Cohen,¹ P. Reese,¹ P. Porrett,² R. Bloom,¹ K. Forde,³ D. Sawinski.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z